China, Thailand and Malaysia all offer credible IVF at substantial savings vs Western private rates. The choice rarely comes down to price alone — here is what actually matters.
Standard IVF + ICSI cycle for international patients, all-in including stimulation medications:
The Headline Comparison
Standard IVF + ICSI cycle for international patients, all-in including stimulation medications:
- China (Class A reproductive medicine centres) — USD 5,500–9,500
- Thailand (Bangkok premium clinics) — USD 7,500–12,000
- Malaysia (KL premium clinics) — USD 6,000–10,500
- India (top Mumbai / Delhi clinics) — USD 4,000–7,000
- US private — USD 18,000–30,000
- UK private — USD 8,000–14,000
On a pure-price basis, India is the cheapest among credible destinations; China is comparable to Malaysia and roughly USD 2,000–3,000 below typical Thailand premium. PGT-A adds USD 1,400–2,200 across all destinations.
What's Different Beyond Price
For IVF, four factors meaningfully shift the calculation:
- Lab volume and quality assurance. PKU Third Hospital (Beijing) and Renji (Shanghai) are among the highest-volume reproductive medicine centres globally. Lab volume drives technical consistency.
- Donor egg / embryo / surrogacy availability. China heavily restricts donor programmes for international patients; surrogacy is not permitted. Thailand has tightened over the past decade. Malaysia varies. Patients requiring donor gametes have different optimal destinations.
- Single-cycle vs cumulative-cycle pricing. Some Bangkok and KL clinics offer multi-cycle packages with money-back-guarantee structures; this is not standard at Chinese academic centres, which charge cycle-by-cycle.
- Visa and trip length. China M-visa with hospital invitation runs 4–7 business days for processing; Thailand and Malaysia visa-free or visa-on-arrival for many nationalities. For multi-trip programmes (egg freezing, frozen embryo transfer cycles), visa logistics matter.
Where China Wins Decisively
- Complex cases: PCOS-related infertility, severe male factor, recurrent implantation failure, fertility preservation in cancer patients — academic medical centre depth at PKU Third / Renji is meaningful.
- PGT-M (single-gene disorders): custom probe development capacity at major academic centres.
- Integrated reproductive endocrinology: patients with concurrent PCOS, thyroid disease, or metabolic comorbidities benefit from co-located endocrinology.
Where Thailand or Malaysia May Be Better
- Single straightforward IVF cycle without complex factors
- Donor egg / embryo programmes (where legal in destination)
- Patients who prefer English-default operations and resort-style accommodation
- Multi-cycle package structures with money-back-guarantee offerings
How to Decide
Take our free female fertility self-screener for a structured assessment. The output identifies whether your case is "straightforward" (where price-led decisions are reasonable) or "complex" (where academic-centre depth is the right call). For procedure detail and partner centres, see our IVF in China page.
Sources: Partner-hospital reproductive medicine pricing 2026; published cross-country IVF cost analyses; ASRM and ESHRE clinical guidance.